Your browser doesn't support javascript.
loading
Comparison of Sleep Apnea Questionnaires and Reported Diagnosis in Neurological Disorders of Aging.
Gomes, Teresa; Benedetti, Andrea; Postuma, Ron; Rizzo, Dorrie; Baltzan, Marc; Kimoff, Richard John; Kaminska, Marta.
Afiliación
  • Gomes T; Department of Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada.
  • Benedetti A; Respiratory Epidemiology and Clinical Research Unit, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • Postuma R; Respiratory Epidemiology and Clinical Research Unit, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • Rizzo D; Department of Medicine and Department of Epidemiology, Biostatistics & Occupational Health, McGill University Health Centre, Montreal, QC, Canada.
  • Baltzan M; Department of Neurology and Neurosurgery, McGill University, Montreal General Hospital, Montreal, QC, Canada.
  • Kimoff RJ; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
  • Kaminska M; Mount Sinai Hospital Center, Montreal, QC, Canada.
Can J Neurol Sci ; : 1-7, 2024 May 17.
Article en En | MEDLINE | ID: mdl-38757562
ABSTRACT

BACKGROUND:

Obstructive sleep apnea (OSA) is associated with worse outcomes in stroke, Alzheimer's disease (AD) and Parkinson's disease (PD), but diagnosis is challenging in these groups. We aimed to compare the prevalence of high risk of OSA based on commonly used questionnaires and self-reported OSA diagnosis 1. within groups with stroke, AD, PD and the general population (GP); 2. Between neurological groups and GP.

METHODS:

Individuals with stroke, PD and AD were identified in the Canadian Longitudinal Study of Aging (CLSA) by survey. STOP, STOP-BAG, STOP-B28 and GOAL screening tools and OSA self-report were compared by the Chi-squared test. Logistic regression was used to compare high risk/self-report of OSA, in neurological conditions vs. GP, adjusted for confounders.

RESULTS:

We studied 30,097 participants with mean age of 62.3 years (SD 10.3) (stroke n = 1791; PD n = 175; AD n = 125). In all groups, a positive GOAL was the most prevalent, while positive STOP was least prevalent among questionnaires. Significant variations in high-risk OSA were observed between different questionnaires across all groups. Under 1.5% of individuals self-reported OSA. While all questionnaires suggested a higher prevalence of OSA in stroke than the GP, for PD and AD, there was heterogeneity depending on questionnaire.

CONCLUSIONS:

The wide range of prevalences of high risk of OSA resulting from commonly used screening tools underscores the importance of validating them in older adults with neurological disorders. OSA was self-reported in disproportionately small numbers across groups, suggesting that OSA is underdiagnosed in older adults or underreported by patients, which is concerning given its increasingly recognized impact on brain health.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Can J Neurol Sci Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Can J Neurol Sci Año: 2024 Tipo del documento: Article País de afiliación: Canadá